Augmont Enterprises IPO Day 2: GMP ₹280

Welcome back, IPO enthusiasts! It’s Day 2 of the Augmont Enterprises IPO, and we’re diving deep into the latest subscription figures and Grey Market Premium (GMP) to see how this mainboard offering on the NSE is shaping up. As of today, the Augmont Enterprises IPO continues its journey through its subscription window, which runs from August 21st to August 25th, 2026. With an issue price set at ₹788 per share, investors are closely watching every move. Let’s break down what we’re seeing on Day 2.

Subscription Status

As of Day 2, the subscription numbers for Augmont Enterprises IPO are showing a flat zero across all categories: Retail, Non-Institutional Investors (NII), and Qualified Institutional Buyers (QIB). This might sound alarming at first glance, but it’s not entirely uncommon, especially in the early stages of an IPO. The IPO period is quite extensive, running until August 25th, which gives investors ample time to review and decide. The fact that we’re seeing 0x subscription across the board on Day 2 simply means that the formal subscription process hasn’t yet gained significant traction. Often, retail investors, in particular, tend to wait until the latter half of the subscription period to place their bids. For NII and QIB categories, their participation usually picks up pace closer to the closing date as well, allowing them to assess market sentiment and other investment opportunities. The lot size is 19 shares, so a full subscription would mean a substantial number of applications. We’ll be keeping a close eye on how these numbers evolve over the next few days. This lack of initial movement doesn’t necessarily spell doom, but it’s something to monitor.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Augmont Enterprises IPO stands firm at ₹280. Interestingly, this figure has remained unchanged from yesterday’s update. This stability in GMP is often a positive sign, suggesting that the market sentiment surrounding the IPO is consistent. A GMP of ₹280 on an issue price of ₹788 indicates a potential listing price of around ₹1068 (₹788 + ₹280). This expected listing price represents a healthy premium over the issue price, which is encouraging for potential investors. While GMP is not an official indicator, it often provides a good sense of the demand and perceived value of the company in the unlisted market. The unchanged GMP means that the initial buzz hasn’t faded, nor has it significantly amplified. It suggests a steady confidence among those trading in the grey market.

Should You Apply?

So, the big question: should you apply for the Augmont Enterprises IPO? On one hand, the GMP is showing a consistent and attractive premium, hinting at a potentially strong listing. The expected listing price of ₹1068 is definitely something to consider. However, the subscription figures on Day 2 are still at zero across all categories. This means that the market’s actual appetite, as reflected in formal applications, is yet to be seen. It’s crucial to remember that SEBI advises investors to conduct their own due diligence before investing. While the GMP is a useful gauge, it’s not the only factor. The company’s fundamentals, future prospects, and the overall market conditions are equally important. The extended subscription period gives you time to research and wait for clearer subscription trends. The bottom line is that the potential upside indicated by the GMP is promising, but the lack of early subscription momentum warrants cautious observation. We’ll need to see how the subscription numbers pick up in the coming days to form a more definitive opinion. For those looking for more details, you can View Full Augmont Enterprises IPO Details.